The immunology of inflammatory bowel disease continues to be an intense are
a of investigation for clues to the pathogenesis of Crohn disease and ulcer
ative colitis. As typical with complex diseases, inflammatory bowel disease
research is continuously evolving. Without abandoning traditional areas of
study, such as humoral and cellular immunity and cytokines, investigation
is broadening to explore new molecules and biologic phenomena. Novel cytoki
nes and cell adhesion molecules appear to be invoked in inflammation, while
the role of nitric oxide is being clarified. Leukocyte resistance to apopt
osis appears to be a major contributing factor to Crohn disease. Epithelial
cell-derived defensins and receptors are arising as key molecules mediatin
g the interaction of innate and acquired mucosal immunity with the enteric
flora, and explaining how the latter participates in gut inflammation. The
results of these combined studies are opening novel therapeutic horizons wh
ose implementation offers better forms of treatment. Curr Opin Gastroentero
l 2000 16:306-309 (C) 2000 Lippincott Williams & Wilkins, Inc.